Source: Annual Congress 2007 - Chronic lung disease of prematurity: pathogenesis and outcomes
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. May, O. Williams, A. Milner, G. Rafferty, S. Hannam, A. Greenough (London, United Kingdom). Exhaled nitric oxide levels and severity of bronchopulmonary dysplasia (BPD) development. Eur Respir J 2007; 30: Suppl. 51, 4411

Member's Comments

No comment yet.

Related content which might interest you: Fractional exhaled nitric oxide in infants with different degrees of bronchopulmonary dysplasia Source: Eur Respir J 2005; 26: Suppl. 49, 614s Year: 2005 Exhaled nitric oxide (FeNO) in relation to exacerbation of childhood asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Exhaled nitric oxide in infants: a marker of inflammation? Source: Eur Respir Monogr 2010; 49: 56-70 Year: 2010 Exhaled nitric oxide and clinical phenotype of childhood asthma Source: Annual Congress 2011 - Inflammation and genes in childhood asthma Year: 2011 Exhaled nitric oxide in children with severe asthma Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood Year: 2012 Exhaled nitric oxide (eNO): an early indicator of asthma relapse in children Source: Eur Respir J 2005; 26: Suppl. 49, 42s Year: 2005 Fractional exhaled nitric oxide (FeNO) for an early diagnosis of asthma Source: Eur Respir J 2006; 28: Suppl. 50, 677s Year: 2006 Exhaled nitric oxide is related to asthma control but not severity Source: Eur Respir J 2004; 24: Suppl. 48, 260s Year: 2004 Exhaled nitric oxide (NO) detection for monitoring airway inflammation in non-severe CAP Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008 Diagnosing asthma using exhaled nitric oxide (eNO) measurements Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma Year: 2003 Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma Source: Eur Respir J 2008; 32: 344-349 Year: 2008 Exhaled nitric oxide (eNO) as a noninvasive assessment of recurrent wheezers in adults Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005 Fractional exhaled nitric oxide in infants with bronchopulmonary dysplasia, cystic fibrosis and recurrent wheezing Source: Eur Respir J 2005; 26: Suppl. 49, 674s Year: 2005 Exhaled nitric oxide is not reduced in infants with cystic fibrosis Source: Eur Respir J 2006; 27: 350-354 Year: 2006 Screening with exhaled nitric oxide (ENO) may identify cases with on-going bronchial inflammation but not asthma symptoms Source: Eur Respir J 2001; 18: Suppl. 33, 38s Year: 2001 Fractional exhaled nitric oxide is associated with more severe asthma Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Exhaled nitric oxide and pulmonary function tests in children with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 759s Year: 2007 Stability of exhaled nitric oxide (FENO) in patients with severe, steroid-dependent asthma Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008 Exhaled nitric oxide is more a biomarker of atopy than asthma Source: Annual Congress 2009 - Inflammation and airways Year: 2009 Exhaled nitric oxide during infancy as a risk factor for asthma and airway hyperreactivity Source: Eur Respir J 2015; 45: 98-106 Year: 2015